SERUM LAMININ-P1 IN DIABETES-MELLITUS - USEFULNESS AS AN INDEX OF DIABETIC-RETINOPATHY

被引：0
|
作者：
MATEO, C
MASMIQUEL, LL
SIMO, R
ARUMI, JG
COLIN, A
机构：
[1] UNIV AUTONOMA BARCELONA,DEPT OPHTHALMOL,BARCELONA,SPAIN
[2] UNIV AUTONOMA BARCELONA,DEPT ENDOCRINOL,BARCELONA,SPAIN
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1994年 / 35卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1592 / 1592
页数：1
相关论文
共 50 条
  • [31] SERUM LAMININ-P1 FRAGMENT CONCENTRATION IN RENAL DISEASES
    HORIKOSHI, S
    KOIDE, H
    CLINICA CHIMICA ACTA, 1991, 196 (2-3) : 185 - 191
  • [32] PROLIFERATIVE DIABETIC-RETINOPATHY IS RELATED TO CARDIOVASCULAR AUTONOMIC NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    SCHMID, H
    SCHAAN, B
    CECCONELLO, F
    MAESTRI, T
    NEUMANN, C
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1995, 29 (03) : 163 - 168
  • [33] AGGREGATE FORMATION OF ERYTHROCYTES AND DIABETIC-RETINOPATHY IN CHILDREN, ADOLESCENTS, AND ADULTS WITH DIABETES-MELLITUS (TYPE-I)
    TILLMANN, W
    LAKOMEK, M
    HEIDEMANN, P
    BEHRENSBAUMANN, W
    SCHROTER, W
    KLINISCHE WOCHENSCHRIFT, 1984, 62 (23): : 1136 - 1139
  • [34] THE EFFECT OF INTENSIVE DIABETES TREATMENT ON THE PROGRESSION OF DIABETIC-RETINOPATHY IN INSULIN-DEPENDENT DIABETES-MELLITUS - THE DIABETES CONTROL AND COMPLICATIONS TRIAL
    SHAMOON, H
    DUFFY, H
    FLEISCHER, N
    ENGEL, S
    SAENGER, P
    STRELYZN, M
    LITWAK, M
    WYLIEROSETT, J
    FARKASH, A
    GEIGER, D
    ENGEL, H
    FLEISCHMAN, J
    POMPI, D
    GINSBERG, N
    GLOVER, M
    BRISMAN, M
    WALKER, E
    THOMASUNIS, A
    GONZALEZ, J
    GENUTH, S
    DAHMS, W
    BROWN, E
    PUGSLEY, P
    MAYER, L
    KERR, D
    LANDAU, B
    SINGERMAN, L
    RICE, T
    NOVAK, M
    SMITHBREWER, S
    MCCONNELL, J
    DROTAR, D
    WOODS, D
    LITVENE, M
    KATIRJI, B
    BROWN, C
    CAMPBELL, R
    RICHARDSON, M
    LACKAYE, M
    LEVY, B
    CHANG, S
    HEINHEINEMANN, M
    BARRON, S
    ASTOR, L
    LEBECK, D
    BRILLON, D
    DIAMOND, B
    VASILASDWOSKIN, A
    BRISMAN, M
    LAURENZI, B
    ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (01) : 36 - 51
  • [35] SERUM LAMININ AND IN-VIVO PLATELET ACTIVATION IN DIABETES-MELLITUS
    BURGOS, R
    SIMO, R
    MASMIQUEL, L
    GARCIAPASCUAL, L
    SEGURA, RM
    MESINA, J
    DIABETOLOGIA, 1994, 37 : A208 - A208
  • [36] DIABETIC-RETINOPATHY AND VISUAL-ACUITY IN TYPE-2 DIABETES-MELLITUS - RESULTS OF A NATIONAL PREVENTION PROGRAM
    STEFANSSON, E
    KRISTINSSON, JK
    GISLASON, I
    JONASSON, F
    BJORNSSON, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 879 - 879
  • [37] A 4-YEAR FOLLOW-UP-STUDY ON THE INCIDENCE OF DIABETIC-RETINOPATHY IN OLDER ONSET DIABETES-MELLITUS
    AGARDH, E
    AGARDH, CD
    KOUL, S
    TORFFVIT, O
    DIABETIC MEDICINE, 1994, 11 (03) : 273 - 278
  • [38] Serum lipid levels and diabetic retinopathy in type 1 diabetes mellitus
    Miljanovic, BM
    Glynn, RJ
    Nathan, DM
    Manson, JE
    Schaumberg, DA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U114 - U114
  • [39] SERUM IGF-1 CONCENTRATION IN DIABETIC-RETINOPATHY
    HYER, SL
    SHARP, PS
    BROOKS, RA
    BURRIN, JM
    KOHNER, EM
    DIABETIC MEDICINE, 1988, 5 (04) : 356 - 360
  • [40] DIABETIC-RETINOPATHY REMAINS STABLE AFTER COMBINED KIDNEY AND PANCREAS TRANSPLANTATION FOR TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS
    SCHEIDER, A
    THURAU, S
    ULBIG, M
    KAMPIK, A
    MEYERSCHWICKERATH, E
    NUSSER, J
    ILLNER, WD
    LAND, W
    ABENDROTH, D
    LANDGRAF, R
    DIABETOLOGIA, 1989, 32 (07) : A538 - A538
12345